Explore our strategic phases:

With a growing range of new vaccines coming on to the market and evidence that some countries simply could not sustain the significant increases in funding required to maintain immunisation programmes, Gavi's first-ever strategy incorporated a detailed review of how best to deploy its growing resources:

STRATEGIC GOALS

Four strategic goals underpinned Phase II

Credit: Gavi/2008/Sala Lewis

Strategic Goal 1

Contribute to the strengthening the capacity of the health system to deliver immunisation and other health services in a sustainable manner.

Credit: Gavi/2012/Adrian Brooks

Strategic Goal 2

Accelerate the uptake and use of underused and new vaccines and associated technologies and improve vaccine supply security.

Credit: Gavi/2013/Evelyn Hockstein/Congo DRC

Strategic Goal 3

Increase the predictability and sustainability of long-term financing for national immunisation programmes.

Credit: Gavi/2014/Duncan Graham-Rowe/Cameroon

Strategic Goal 4 

Increase and assess the added value of Gavi as a public-private global health partnership through improved efficiency, increased advocacy and continued innovation.

WORKPLAN, ACTIVITIES, OUTPUTS

With a total budget of US$ 297 million available for the strategy's four-year life cycle, any given year in the Gavi strategy contained up to 100 activities. To help measure progress, these activities are reported against 17 outputs.

The 2010 Work Plan Report highlights the 2010 progress under each output. It is based on the reporting provided by WHO, UNICEF, World Bank, AVI TAC and the Gavi Secretariat. The paper includes an annex table summarising the progress per output against the 2010 work plan targets.

Related downloads

Latest news

New “blockbuster” tuberculosis vaccines could save seven million lives by 2050

Next-generation TB vaccines, expected to become available from 2029, could deliver major health and economic gains, helping to save an estimated 7.3 million lives, generate up to US$ 135 billion in economic benefits for low-and middle-income…

Papua New Guinea launches HPV vaccination to protect girls from cervical cancer

Cervical cancer remains one of the leading causes of cancer-related deaths for women in Papua New Guinea, with over 1,000 women diagnosed and ~650 deaths annually.

Last updated: 21 May 2026